These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29724913)

  • 1. IL1β and TNFα promote RANKL-dependent adseverin expression and osteoclastogenesis.
    Wang Y; Galli M; Shade Silver A; Lee W; Song Y; Mei Y; Bachus C; Glogauer M; McCulloch CA
    J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29724913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1.
    Song MK; Lee ZH; Kim HH
    Exp Mol Med; 2015 Dec; 47(12):e199. PubMed ID: 26642432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The actin binding protein adseverin regulates osteoclastogenesis.
    Hassanpour S; Jiang H; Wang Y; Kuiper JW; Glogauer M
    PLoS One; 2014; 9(9):e109078. PubMed ID: 25275604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-alpha expression is transcriptionally regulated by RANK ligand.
    Zou W; Amcheslavsky A; Takeshita S; Drissi H; Bar-Shavit Z
    J Cell Physiol; 2005 Feb; 202(2):371-8. PubMed ID: 15389596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of l-caldesmon on osteoclastogenesis in RANKL-induced RAW264.7 cells.
    Liou YM; Chan CL; Huang R; Wang CA
    J Cell Physiol; 2018 Sep; 233(9):6888-6901. PubMed ID: 29377122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 26 suppresses receptor activator of nuclear factor κB ligand induced osteoclastogenesis via down-regulation of nuclear factor of activated T-cells, cytoplasmic 1 and nuclear factor κB activity.
    Peng YJ; Wang CY; Lin YH; Lin GJ; Huang SH; Shyu JF; Sytwu HK; Cheng CP
    Rheumatology (Oxford); 2016 Nov; 55(11):2074-2083. PubMed ID: 27550297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptor 84 controls osteoclastogenesis through inhibition of NF-κB and MAPK signaling pathways.
    Park JW; Yoon HJ; Kang WY; Cho S; Seong SJ; Lee HW; Yoon YR; Kim HJ
    J Cell Physiol; 2018 Feb; 233(2):1481-1489. PubMed ID: 28574596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts.
    O' Gradaigh D; Ireland D; Bord S; Compston JE
    Ann Rheum Dis; 2004 Apr; 63(4):354-9. PubMed ID: 15020327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
    Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
    Asai K; Funaba M; Murakami M
    Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways.
    Nakao A; Fukushima H; Kajiya H; Ozeki S; Okabe K
    Biochem Biophys Res Commun; 2007 Jun; 357(4):945-50. PubMed ID: 17467668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(adp-ribose) polymerase-1 regulates Tracp gene promoter activity during RANKL-induced osteoclastogenesis.
    Beranger GE; Momier D; Rochet N; Carle GF; Scimeca JC
    J Bone Miner Res; 2008 Apr; 23(4):564-71. PubMed ID: 18021007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
    Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
    PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways.
    Li CH; Xu LL; Jian LL; Yu RH; Zhao JX; Sun L; Du GH; Liu XY
    Int Immunopharmacol; 2018 May; 58():136-144. PubMed ID: 29587202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adseverin knockdown inhibits osteoclastogenesis in RAW264.7 cells.
    Qi W; Gao Y; Tian J; Jiang H
    Int J Mol Med; 2014 Dec; 34(6):1483-91. PubMed ID: 25339151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.